← Leaderboards
Alphonse E Sirica
Virginia Commonwealth University
$7,545,503
Attributed
$7,545,503
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $594.4K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,545,503 · 5
By mechanism
R01$7,519,253 · 2
R13$26,250 · 3
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Paul B Fisher$21,846,479
- Paul Dent$11,860,656
- Bin Gao$700,617
- Steven Grant$20,337,700
- Gordon D Ginder$21,192,432
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionIntrahepatic CholangiocarcinomaMolecularIncidenceCholangiocarcinomaMalignant NeoplasmsMalignant - DescriptorLinkFundingClinical TrialsGrantLiverBaseDisease /Disorder ModelIn VitroCholangiocyteIn VivoLaboratoriesGrowthClinically RelevantCell LineExhibitsCellsHepatic
Grant awards (29)
The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine$14,000
R13 · FY2023 · CA · contact PI
Altered Growth Factor Pathways in Biliary Cancer$307,269
R01 · FY2017 · CA · contact PI
Hepatobiliary Cancers: Pathobiology and Translational Advances$2,250
R13 · FY2017 · CA · contact PI
Altered Growth Factor Pathways in Biliary Cancer$307,269
R01 · FY2016 · CA · contact PI
Altered Growth Factor Pathways in Biliary Cancer$307,269
R01 · FY2015 · CA · contact PI
Altered Growth Factor Pathways in Biliary Cancer$298,051
R01 · FY2014 · CA · contact PI
Altered Growth Factor Pathways in Biliary Cancer$307,017
R01 · FY2013 · CA · contact PI
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO$280,284
R01 · FY2011 · CA · contact PI
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO$288,953
R01 · FY2010 · CA · contact PI
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER$302,232
R01 · FY2009 · CA · contact PI
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO$288,953
R01 · FY2009 · CA · contact PI
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER$302,232
R01 · FY2008 · CA · contact PI
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO$288,953
R01 · FY2008 · CA · contact PI
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER$302,232
R01 · FY2007 · CA · contact PI
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO$279,450
R01 · FY2007 · CA · contact PI
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER$311,259
R01 · FY2006 · CA · contact PI
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER$318,750
R01 · FY2005 · CA
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO$275,681
R01 · FY2005 · CA
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO$275,681
R01 · FY2004 · CA
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER$261,895
R01 · FY2004 · CA
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER$287,904
R01 · FY2003 · CA
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO$275,681
R01 · FY2003 · CA
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER$280,546
R01 · FY2002 · CA
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO$275,681
R01 · FY2002 · CA
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO$275,681
R01 · FY2001 · CA
ALTERED GROWTH FACTOR PATHWAYS IN BILLIARY CANCER$273,422
R01 · FY2001 · CA
FASEB Growth Factor Receptor Tyrosine Kinases Confence$10,000
R13 · FY2001 · CA
ALTERED GROWTH FACTOR PATHWAYS IN BILLIARY CANCER$277,690
R01 · FY2000 · CA
HEPATIC OVAL CELLS IN CULTURE AND IN VIVO$269,218
R01 · FY2000 · CA